Skip to main content

Table 1 Flow cytometry analysis of the percentages of T lymphocyte subsets (mean ± SD, %)

From: Molecular characterisation and the protective immunity evaluation of Eimeria maxima surface antigen gene

Marker

Group

Pre-immunized (%)

1st immunized (%)

2nd immunized (%)

CD4+

PBS

23.74 ± 3.21a

24.18 ± 1.94a

24.68 ± 3.58a

pVAX1.0 control

24.28 ± 3.67a

25.26 ± 3.55a

25.12 ± 2.84a

pET-32a(+) control

24.04 ± 3.39a

23.32 ± 2.88a

24.50 ± 2.13a

rEmSAG

23.12 ± 3.4a

28.14 ± 4.67a

35.70 ± 2.94b

pVAX-EmSAG

24.96 ± 1.66a

35.24 ± 3.51b

40.92 ± 7.66b

CD8+

PBS

34.74 ± 3.13a

34.18 ± 3.94a

35.16 ± 1.94a

pVAX1.0 control

34.64 ± 1.35a

35.26 ± 3.65a

35.08 ± 2.89a

pET-32a(+) control

35.32 ± 2.57a

34.20 ± 5.37a

34.84 ± 3.72a

rEmSAG

34.8 ± 6.19a

45.44 ± 3.83b

57.02 ± 1.85b

pVAX-EmSAG

34.28 ± 5.61a

49.04 ± 2.76b

64.28 ± 3.65c

  1. Note: In each column, different letters indicate a significant difference (P < 0.05) between numbers. There is no significant difference (P > 0.05) between numbers with the same letter